COST-EFFECTIVENESS OF ATORVASTATIN IN ACUTE CORONARY SYNDROME PATIENTS IN THE NETHERLANDS

被引：0
|
作者：
Thurston, S. J. [1 ]
Webb, K. [2 ]
Ong, S. [2 ]
Meerding, W. J. [3 ]
van Hout, B. A. [1 ]
机构：
[1] Pharmerit Ltd, York, N Yorkshire, England
[2] Pfizer Ltd, Surrey, England
[3] Pfizer Bv, Capelle aan den IJssel, Netherlands
来源：
VALUE IN HEALTH | 2009年 / 12卷 / 07期
关键词：
D O I：
10.1016/S1098-3015(10)74646-5
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A335 / A335
页数：1
相关论文
共 50 条
  • [21] Cost-effectiveness of prasugrel versus clopidogrel in acute coronary syndrome patients undergoing percutaneous coronary intervention
    Spartalis, Michael
    Tzatzaki, Eleni
    Nikiteas, Nikolaos I.
    Spartalis, Eleftherios
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2018, 251 : 32 - 32
  • [22] Cost-effectiveness of atorvastatin in the early treatment of acute coronary syndromes in Germany based on the MIRACL study
    Lange, AP
    Szucs, TD
    MEDIZINISCHE KLINIK, 2004, 99 (09) : 500 - +
  • [23] Cost-Effectiveness of Fondaparinux in Patients with Acute Coronary Syndrome without ST-Segment Elevation
    Pepe, Camila
    Machado, Marcio
    Olimpio, Alexandre
    Ramos, Rui
    ARQUIVOS BRASILEIROS DE CARDIOLOGIA, 2012, 99 (01) : 613 - 622
  • [24] Cost-effectiveness analysis of ticagrelor compared to clopidogrel for the treatment of patients with acute coronary syndrome in Colombia
    Mejia, Aurelio
    Manuel, Juan, Sr.
    Ceballos, Mateo
    Atehortua, Sara
    Manuel Toro, Juan
    Saldarriaga, Clara
    Elena Mejia, Maria
    Ramirez, Carolina
    BIOMEDICA, 2015, 35 (04): : 531 - 540
  • [25] ANALYSIS OF COST-EFFECTIVENESS AND COST-BENEFIT OF THE RIVAROXABAN ADDITION IN THE TREATMENT OF PATIENTS WITH ACUTE CORONARY SYNDROME IN COLOMBIA
    Romero, M.
    Marrugo, R.
    Paez, M. L.
    VALUE IN HEALTH, 2015, 18 (07) : A830 - A830
  • [26] Comparative Effectiveness of Generic Atorvastatin and Lipitor® in Patients Hospitalized with an Acute Coronary Syndrome
    Jackevicius, Cynthia A.
    Tu, Jack V.
    Krumholz, Harlan M.
    Austin, Peter C.
    Ross, Joseph S.
    Stukel, Therese A.
    Koh, Maria
    Chong, Alice
    Ko, Dennis T.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2016, 5 (04):
  • [27] Cost-effectiveness of ticagrelor in acute coronary syndromes
    Henriksson, Martin
    Janzon, Magnus
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2013, 13 (01) : 9 - 18
  • [28] Cost-effectiveness of low-dose colchicine in patients with chronic coronary disease in The Netherlands
    Fiolet, Aernoud T. L.
    Keusters, Willem
    Blokzijl, Johan
    Nidorf, S. Mark
    Eikelboom, John W.
    Budgeon, Charley A.
    Tijssen, Jan G. P.
    Romer, Tjeerd
    Westendorp, Iris
    Cornel, Jan Hein
    Thompson, Peter L.
    Frederix, Geert W. J.
    Mosterd, Arend
    de Wit, G. Ardine
    EUROPEAN HEART JOURNAL-QUALITY OF CARE AND CLINICAL OUTCOMES, 2024,
  • [29] Cost-effectiveness of coronary MDCT in the triage of patients with acute chest pain
    Ladapo, Joseph A.
    Hoffmann, Udo
    Bamberg, Fabian
    Nagurney, John T.
    Cutler, David M.
    Weinstein, Milton C.
    Gazelle, G. Scott
    AMERICAN JOURNAL OF ROENTGENOLOGY, 2008, 191 (02) : 455 - 463
  • [30] The cost-effectiveness of zemplar in the Netherlands
    Nuijten, MJ
    Siegert, C
    VALUE IN HEALTH, 2006, 9 (03) : A7 - A8
12345